Wyszukaj projekt badawczy
173 Wyniki
Ufundowane przez członka IRDiRC = Członek Europejskiej Sieci Referencyjnej (ERN) =
Projekt badawczy

WIEN
ADDRESS: NOT PROVIDED - AT
A Quality Improvement Project to Implement Psychosocial Care Standards in Clinical Practice in Pediatric Oncology "My Logbook! - I Know my Way Around!" Development and Evaluation of a Consensus and Evidence Based Psychosocial Therapy Tool in a Preliminary Psychosocial Study on Therapy Optimization - AT
Institution: Information not provided - AT

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
Follow-up van de vruchtbaarheid bij jongvolwassenen die het testisweefsel wel of niet hebben opgeslagen vóór de gonadotoxische behandeling voor het behoud van de vruchtbaarheid
Universitair Ziekenhuis Brussel
Universitair Ziekenhuis Brussel (UZ Brussel)

Ontario
TORONTO
Beyond the Genome: Transcriptome Based Diagnostics for Rare Diseases and Cancer
Hospital for Sick Children, Research Institute

ILE-DE-FRANCE
ORSAY
DCD-CANC-CHILD: contrôle de la conception de vecteurs et de la délivrance de médicaments pour le traitement des tumeurs pédiatriques
Université Paris-Sud
Institut de Chimie Moléculaire et des Matériaux d'Orsay

Baden-Württemberg
HEIDELBERG
ERA-NET TRANSCAN: BRCAddict - BRCAness als therapeutisches Ziel bei kindlichen soliden Hochrisiko-Tumoren
Deutsches Krebsforschungszentrum
KITZ - Hopp-Kindertumorzentrum Heidelberg

VENETO
PADOVA
Modulazione dell'asse determinato dalle Bone Morphogenetic Proteins (BMPs) per prevenire la perdita muscolare, la degenerazione della giunzione neuromuscolare e la denervazione nella cachessia provocata dal cancro
Venetian Institute of Molecular Medicine
Fondazione per la ricerca Biomedica avanzata ONLUS

Washington
ADDRESS: NOT PROVIDED - US
Evaluating utility and improving implementation of genomic sequencing for pediatric cancer patients in the diverse population and healthcare settings of Texas: the kidscanseq study
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Personalized whole body staging for children with cancer: a solution to the conundrum of long-term side effects from ct and pet/ct scans
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Project 1: optimization of therapeutic approaches for children with relapsed sarcomas using precision medicine.
Institution: Information not provided - US

WIEN
ADDRESS: NOT PROVIDED - AT
The ROAM trial: Radiation versus Observation following surgical resection of Atypical Meningioma: a randomised controlled trial - AT
Institution: Information not provided - AT

WIEN
WIEN
E-TRAB: Geriatric Assessment of Elderly "Unsuited" Patients Receiving Trabectedin in First Line Treatment For Advanced Soft Tissue Sarcomas - AT
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Onkologie

WIEN
WIEN
Intraoperative Visualisierung von diagnostischem Gewebe mit 5-ALA induzierter PpIX-Fluoreszenzmessung bei stereotaktischen Biopsien von Hirntumoren
Allgemeines Krankenhaus der Stadt Wien
Universitätsklinik für Neurochirurgie

WIEN
WIEN
Verbesserte Visualisierung und Resektion von Hirntumoren mit quantitativer Fluoreszenz unf optischer Kohärenztomographie
Allgemeines Krankenhaus der Stadt Wien
Universitätsklinik für Neurochirurgie

WIEN
WIEN
MEN-301: A Phase 3 Multicenter Study of Gleolan (Aminolevulinic Acid Hydrochloride) to Enhance Visualization of Tumor in Patients With Newly Diagnosed or Recurrent Meningiomas - AT
Allgemeines Krankenhaus der Stadt Wien
Universitätsklinik für Neurochirurgie

WIEN
WIEN
ITCC-P4: Pediatric Preclinical Proof of Concept Platform - AT
Medizinische Universität Wien
Institut für Krebsforschung

WIEN
WIEN
MR Fingerprinting von Patienten mit Gliomas
Medizinische Universität Wien
Exzellenzzentrum für Hochfeld-MR

Nordrhein-Westfalen
BONN
Funktionelle Rolle von Genen und Signalwegen in Histon H3 mutierten Gliomen
Deutsche Forschungsgemeinschaft

Nordrhein-Westfalen
MÜNSTER
Funktionelle Rolle von Genen und Signalwegen in Histon H3 mutierten Gliomen
Institut für Neuropathologie der Medizinischen Fakultät Münster
Institut für Neuropathologie

Rheinland-Pfalz
MAINZ
BLU-Men: Psychologische Belastung und Lebensqualität bei Patienten mit Unbehandelten MENingeomen
Universitätsmedizin Mainz
Neurochirurgische Klinik und Poliklinik

Rheinland-Pfalz
MAINZ
GLIOPT -Gliompatienten in der ambulanten Versorgung - Optimierung der psycho-sozialen Versorgung bei neuroonkologischen Patienten
Universitätsmedizin Mainz
Universitäres Centrum für Tumorerkrankungen (UCT) Mainz

County Dublin
DUBLIN
Are Gliomas in Adults Associated With a Unique Identifying Blood Biomarker Signature?
Beaumont Hospital
Medical Oncology Service

County Dublin
GLASNEVIN
Are Gliomas in Adults Associated With a Unique Identifying Blood Biomarker Signature?
Cancer Trials Ireland

CENTRO
BRAGA
Potenciais biomarcadores preditivos da resposta a terapias anti-RTKs em gliomas: estudo in vitro e in vivo.
Universidade do Minho
Grupo de Neurociências

SUL
LISBOA
Papel da proteína cinase WNK2 como gene supressor de gliomas malignos
Instituto Nacional de Saúde Dr. Ricardo Jorge - Lisboa
Unidade de Investigação e Desenvolvimento

Region Uppsala
UPPSALA
Molekylära mekanismer för gliomutveckling
Uppsala Universitet
Department of Immunology, Genetics and Pathology

Suisse Alémanique
BERN
Metabolic Characterization of Space Occupying Lesions of the Brain Using in Vivo MR- (Spectroscopic) Imaging at 3 Tesla and 7 Tesla
University Hospital Inselspital
Universitätsinstitut für Diagnostische und Interventionelle Neuroradiologie

Greater London
LONDON
Measuring Fatty Acid Oxidation in Gliomas Using 18F-FPIA PET/MRI
Imperial College NHS Trust

South Dakota
SIOUX FALLS
Molecular and Cellular Mechanisms of Choroid Plexus Tumor
Sanford Research
Zhao Lab

Washington
ADDRESS: NOT PROVIDED - US
Targeting histone demethylase activity for the treatment of pediatric brainstem glioma
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Establishing the genomic landscape of human atypical meningiomas
Institution: Information not provided - US

WIEN
WIEN
BRCAddict: BRCAness als Angriffspunkt in high-risk pädiatrischen Tumoren - AT
Allgemeines Krankenhaus der Stadt Wien
Universitätsklinik für Kinder- und Jugendheilkunde

VLAAMS BRABANT
LEUVEN
Longitudinale analyse van gezondheidsgerelateerde kwaliteit van leven bij patiënten met glioom en ontwikkeling van een grootschalige prospectieve database van patiënten met glioom behandeld in UZ Leuven - BE
UZ Leuven - Campus Gasthuisberg
Dienst Neurochirurgie

Ontario
TORONTO
Molecular Determinants of Li-Fraumeni Syndrome Associated Cancers
Hospital for Sick Children, Research Institute

Québec
MONTRÉAL
Identification et caractérisation des gènes impliqués dans la genèse et la progression des astrocytomes pédiatriques
Montreal Children's Hospital Research Institute - McGill University
Department of Pediatrics / Département de pédiatrie

Québec
MONTRÉAL
Rôle du remodelage de la chromatique dans la genèse des astrocytomes pédiatriques et chez les jeunes adultes
Montreal Children's Hospital Research Institute - McGill University
Department of Pediatrics / Département de pédiatrie

Québec
MONTRÉAL
Consortium ICHANGE (International CHildhood Astrocytomas iNtegrated Genomics and Epigenomics)
Montreal Children's Hospital Research Institute - McGill University
Department of Pediatrics / Département de pédiatrie

ILE-DE-FRANCE
VILLEJUIF
BRCAddict: Exploiter le BRCAness en tant que cible thérapeutique dans les tumeurs solides pédiatriques à haut risque - FR (Partener 1)
CLCC Institut Gustave Roussy
Département de Cancérologie de l'enfant et de l'adolescent

Baden-Württemberg
HEIDELBERG
INFORM-Register: Individualisierte Therapie für Rückfälle von bösartigen Tumoren bei Kindern
Deutsches Krebsforschungszentrum
Klinische Kooperationseinheit Pädiatrische Onkologie

Hamburg
HAMBURG
Internationales HIT-MED Register für Kinder, Jugendliche und Erwachsene mit Medulloblastom, Ependymom, Pineoblastom und CNS-primitivem neuroektodermalen Tumor
UKE - Universitätsklinikum Hamburg-Eppendorf
Klinik und Poliklinik für Pädiatrische Hämatologie und Onkologie

Nordrhein-Westfalen
BONN
Funktionelle Rolle und klinische Bedeutung von mutiertem SMARCB1/INI1 Protein in atypischen teratoiden/rhabdoiden Tumoren (AT/RT)
Deutsche Forschungsgemeinschaft

Nordrhein-Westfalen
ESSEN
HIT-REZ-REGISTER: Multinationales multizentrisches Register für Kinder, Jugendliche und junge Erwachsene mit therapierefraktärem, progredientem oder rezidiviertem Medulloblastom, Pineoblastom, primitiv neuroektodermalen Tumor des ZNS (ZNS-PNETs) und Ependymom
Universitätsklinikum Essen
Klinik für Kinderheilkunde III - Abteilung für pädiatrische Hämatologie und Onkologie

Nordrhein-Westfalen
MÜNSTER
Funktionelle Rolle und klinische Bedeutung von mutiertem SMARCB1/INI1 Protein in atypischen teratoiden/rhabdoiden Tumoren (AT/RT)
Institut für Neuropathologie der Medizinischen Fakultät Münster
Institut für Neuropathologie

MARCHE
ANCONA
Incidenza, gestione clinica e fattori molecolari associati con lo sviluppo di eventi avversi legati alla risposta immunitaria in pazienti affetti con cancro trattati con inibitori PD-1 e PD-L1: uno studio prospettico osservazionale
Università Politecnica delle Marche - Polo Didattico
Istituto di Clinica Medica

Asturias
OVIEDO
Producción de un medicamento de terapias avanzadas para el tratamiento de enfermedades raras epiteliales a un coste asumible para el Sistema Nacional de Salud
Centro Comunitario de Sangre y Tejidos de Asturias

Region Stockholm
STOCKHOLM
Ny specifik behandling för barncancer med särskild betoning på Wip-1 i medulloblastom och neuroblastom
Karolinska Institutet - Solna
Department of Women's and Children's Health

Region Stockholm
STOCKHOLM
INTENT: innovativ samverkan för behandling av neuroblastom och medulloblastom
Karolinska Institutet - Solna
Department of microbiology, tumor and cell biology

Greater London
LONDON
Use of DTT to Define Facial Nerve Position in Vestibular Schwannomas
King's College Hospital
King's College Hospital NHS Foundation Trust HQ

South Dakota
SIOUX FALLS
Study of the molecular mechanisms of medulloblastoma initiation and progression
Sanford Research
Zhao Lab

Washington
ADDRESS: NOT PROVIDED - US
Glycolytic regulation of cerebellar development and medulloblastoma tumorigenesis
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Precision medicine for pediatric low-grade gliomas
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Functional genomic analysis of neural crest development
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Mir-155 and runx function in neurofibroma tumorigenesis and therapy
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Regulation of medulloblastoma metastasis by emp1
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Regulation of shh signaling by cellular energetics
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Targeting mechanisms of medulloblastoma formation
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Targeting wee1 in myc driven medulloblasoma
Institution: Information not provided - US

SALZBURG
SALZBURG
Multimodale metabolische Therapie beim Neuroblastom
Universitätsklinikum der Paracelsus Medizinischen Privatuniversität
Universitätsklinik für Kinder- und Jugendheilkunde

WIEN
ADDRESS: NOT PROVIDED - AT
Cochlear Implantation After Gamma Knife Radiosurgery With Evoked Auditory Brain-Stem Response (eABR) and Correlation to Postoperative Hearing Results - a Pilot Study
Institution: Information not provided - AT

WIEN
WIEN
Simultaneous Translabyrinthine Surgery of Vestibular Schwannoma and Cochlear Implantation With Intraoperative eBERA and Correlation to Hearing Results - a Pilot Study
Allgemeines Krankenhaus der Stadt Wien
Universitätsklinik für Hals-, Nasen- und Ohrenheilkunde

WIEN
WIEN
Identifikation immunologischer Charakteristika assoziiert mit der Progression niedriggradiger Gliome
Allgemeines Krankenhaus der Stadt Wien
Universitätsklinik für Neurochirurgie

WIEN
WIEN
Quantitative Messung der 5-ALA-Fluoreszenz für die verbesserte Detektion von niedriggradigen Gliomen
Allgemeines Krankenhaus der Stadt Wien
Universitätsklinik für Neurochirurgie

WIEN
WIEN
Pharmacokinetics of different antibiotics in cerebrospinal fluid in children with malignant brain tumors - a pilot study
Allgemeines Krankenhaus der Stadt Wien
Universitätsklinik für klinische Pharmakologie

WIEN
WIEN
LIQUIDHOPE: Liquid Biopsies für NeuroblastompatientInnen - AT
St. Anna Kinderkrebsforschung
Children's Cancer Research Institute

WIEN
WIEN
PRIMAGE: PRedictive In-silico Multiscale Analytics to support cancer personalized diaGnosis and prognosis, Empowered by imaging biomarkers - AT
St. Anna Kinderkrebsforschung
Children's Cancer Research Institute

WIEN
WIEN
A Post-Authorisation Safety Study Patient Registry of Patients With High-risk Neuroblastoma Being Treated With the Monoclonal Antibody Dinutuximab Beta - AT
St. Anna Kinderkrebsforschung
Children's Cancer Research Institute

Finland
HELSINKI
Lessons learned from the embryo to help understand neuroblastoma formation
University of Helsinki
Department of Biochemistry and Developmental Biology

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
Génétique et bases moléculaires des hypoventilations centrales (syndrome d'Ondine)
Institution: Information not provided - FR

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
Génétique et bases moléculaires de syndromes malformatifs avec prédisposition tumorale
Institution: Information not provided - FR

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
PRIMAGE: Analyse multidimensionnelle prédictive In-silico pour prendre en charge la diaGnose et le pronostic personnalisés pour le cancer, renforcés par des biomarqueurs d'imagerie - FR
Institution: Information not provided - FR

AUVERGNE-RHONE-ALPES
LYON
Programme métastatique du neuroblastome: élucider les dialogues moléculaires des cellules tumorales avec le microenvironnement embryonnaire
Institut NeuroMyoGène
NEURO-DÉVELOPPEMENT, CANCER ET SIGNALISATION

ILE-DE-FRANCE
PARIS
LIQUIDHOPE: Faire avancer les biopsies liquides pour la surveillance et le traitement personnalisé d'enfants atteints de neuroblastomes - FR
CLCC Institut Curie
Institut Curie

Nordrhein-Westfalen
KÖLN
Analyse der molekularen Grundlagen von Tumorprogression und spontaner Regression beim Neuroblastom
Universitätsklinikum Köln
Pädiatrische Onkologie und Hämatologie

Sachsen
LEIPZIG
NB-MolBiol-2020: Studie zur klinischen Bedeutung von zellbiologischen Parametern in der Diagnostik, Prognostik und Therapie für Neuroblastom Patienten
Zentrum für Frauen- und Kindermedizin am Universitätsklinikum Leipzig
Abteilung für Pädiatrische Onkologie, Hämatologie und Hämostaseologie

KOREA, REPUBLIC OF
SEOUL
Hypoxiinducerade faktorer-2 (HIF-2) och tumöraggressivitet vid neuroblastom
Seoul National University Hospital
Molecular Diagnostics Laboratory

Cataluña
BARCELONA
Análisis de KIF11 como nueva diana terapéutica en neuroblastoma
Vall d'Hebron Institut de Recerca VHIR
Grupo de investigación traslacional en cáncer en la infancia y la adolescencia

Madrid
MADRID
Terapia para el tratamiento de neuroblastoma basada en el uso del sistema de edición génica CRISPR/Cas9
Centro Nacional de Investigaciones Oncológicas (CNIO)
Unidad de Citogenética Molecular

Madrid
MADRID
Combinación de nanomedicina e inmunoterapia para el tratamiento del neuroblastoma
Hospital Infantil Universitario Niño Jesús
Servicio de Oncohematología

Washington
ADDRESS: NOT PROVIDED - US
Targeting olig2 co-regulators for malignant glioma therapy
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Drug repurposing screening for rare and neglected diseases
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Deconstruct tumor microenvironment in medulloblastoma
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Focal sustained release chemotherapy-loaded biomaterials at tumor sites
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Targeting bet-bromodomains in neuroblastoma
Institution: Information not provided - US

WIEN
ADDRESS: NOT PROVIDED - AT
RESURGE: Randomized Controlled Comparative Phase II Trial on Surgery for Glioblastoma Recurrence - AT
Institution: Information not provided - AT

WIEN
ADDRESS: NOT PROVIDED - AT
Molecular Genetic, Host-derived and Clinical Determinants of Long-term Survival in Glioblastoma - AT
Institution: Information not provided - AT

WIEN
WIEN
TERT Promoter Mutationen und Tumoraggressivität
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Onkologie

WIEN
WIEN
Fibroblast Growth Factor Receptor 4 im Glioblastom
Medizinische Universität Wien
Institut für Krebsforschung

Finland
KUOPIO
New therapeutic treatments for malignant glioma
Itä-Suomen yliopisto
A.I.Virtanen -Instituutti

Finland
KUOPIO
LAT1-targeted prodrugs for improved drug delivery to invasive glioma cells
University of Eastern Finland
Faculty of Health Sciences

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
GLIOMA-PRD: Analyse multi-paramétrique de l'évolution et de la progression des gliomes de bas grade - FR
Institution: Information not provided - FR

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
IMMUNOGLIO: Décrypter la réponse immunitaire contre le glioblastome pour trouver de nouvelles cibles - FR
Institution: Information not provided - FR

AUVERGNE-RHONE-ALPES
ILLKIRCH
Biologie systémique de l'apoptose induite par l'inhibition de l'intégrine pour un nouveau traitement du glioblastome
LBP - Laboratory of Bioimaging and Pathologies
Tumoral signaling and therapeutic targets

AUVERGNE-RHONE-ALPES
LYON
Identification de réseaux d'évènements d'épissage alternatif qui coordonnent l'hétérogénéité cellulaire et la résistance aux thérapies des glioblastomes
Centre de Recherche en Cancérologie Lyon-Est
Diversité du transcriptome des cellules souches

BRETAGNE
RENNES
Activité tumorale d'IRE1 et remodelage du micro- environnement immunitaire des glioblastomes
Centre de Lutte Contre le Cancer Eugène Marquis
Oncogenesis, Stress & Signaling Laboratory

NORMANDIE
CAEN
Radiosensibilisation et réoxygénation des tumeurs par l'intermédiaire de zéolithes contenant du gadolinium : une approche théranostique originale pour les glioblastomes
GIP CYCERON
Equipe CERVOxy | Hypoxie, physiopathologies cérébrovasculaire et tumorale

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE
Développement d'une nouvelle thérapie médicamenteuse pour le glioblastome
Parc scientifique et technologiques de Luminy
Pharmaxon

Nordrhein-Westfalen
DÜSSELDORF
Untersuchung von HOTAIRM1 zur Therapieoptimierung im Glioblastom Multiforme
Universitätsklinikum Düsseldorf
Hirntumor-Referenzzentrum der DGNN

CENTRO
BRAGA
O Transcriptoma da Homeoproteína Oncogénica HOXA9 em Glioblastomas Humanos: Caracterização e Consequências Funcionais
Universidade do Minho
Centro de Ciências e Tecnologias de Computação

Castilla - La Mancha
ALBACETE
Nanomedicina en la terapia del glioblastoma
Universidad de Castilla-La Mancha. Campus de Albacete. Facultad de Medicina
Unidad Neurodeath

Cataluña
BADALONA
Caracterización molecular del glioblastoma: correlación clínico-radiológica, genómica, transcriptómica e inmunohistoquimica
ICO Badalona - Hospital Germans Trias i Pujol
Servicio de Oncología Médica

Comunidad Valenciana
VALENCIA
Perfiles ómicos personales integrativos en la recurrencia y la resistencia a terapia del glioblastoma
IIS La Fe - Instituto de Investigación Sanitaria La Fe
GIBI230: Grupo de Investigación Biomédica en Imagen

Galicia
SANTIAGO DE COMPOSTELA
Nano-trampa implantable de fibroína de seda para el tratamiento del glioblastoma
Universidad de Santiago de Compostela. Facultad de Farmacia
I+D Farma

Madrid
MADRID
Nanomedicina en la terapia del glioblastoma
Hospital Universitario Ramón y Cajal
Servicio de Oncología Médica

Navarra
PAMPLONA
Papel del RNU6 aislado de exosomas circulantes como marcador diagnóstico y de seguimiento en pacientes con glioblastoma
CIMA - Centro de Investigación Médica Aplicada
Grupo de Terapias avanzadas para tumores sólidos pediátricos

Region Uppsala
UPPSALA
Kartläggning av expressionsprofiler kopplade till tumörbildande förmåga och cytostatikaresistens vid humana glioblastom
Uppsala Universitet
Department of Immunology, Genetics and Pathology

Cambridgeshire
CAMBRIDGE
Surgically Induced Neurological Deficits in Glioblastomas (SIND Study) (SIND)
University of Cambridge
MRC Cancer Unit

Washington
ADDRESS: NOT PROVIDED - US
Role of a novel troy-egfr complex in gliobastoma invasion and resistance
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Immunobiology of malignant glioma
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Glioblastoma phenotype modulation through mirna control of wnt signaling
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Autophagy regulation of glioblastoma tumorigenesis and responses to therapy
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Endothelial plasticity in glioma vascularization and therapy resistance
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Targeting prmt5 in cancer initiating cells as a new therapy for glioblastoma
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Hypoxia regulates notch turnover in glioma stem cells through vasorin
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Identification of small molecule inhibitors of phf5a for glioblastoma
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Comparative mammalian genomics
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Cytochrome c oxidase: biomarker in newly diagnosed glioblastoma multiforme
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Dual inhibition of mitochondrial matrix chaperones and anti-apoptotic bcl-2 family members for glioblastoma therapy.
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Glioblastoma stem cell-derived pericytes and cancer invasion
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Investigation of histone h3 post-translational modifications in pediatric brainstem glioma
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Modeling malignant progression in glioma
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Nanofiber matrices to improve neural stem cell-mediated cancer therapy
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Neuronal activity-regulated mechanisms of glioma growth
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Neuroimmunology of malignant brain tumors: innate mechanisms
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Novel k27m mutation-derived neoantigen for t cell therapy in gliomas
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Role of glud2 as a metabolic driver of gliomas with idh1 mutations
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Plexin-b2 function in glioma invasion and glioma stem cell maintenance
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Radiation + temozolomide induced mutation and malignant progression of gbm
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Quantifying differences in mtor activity and tumor development between neural stem cell microdomains
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Regulation of glioblastoma stem-like cells by cdc20-anaphase-promoting complex
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Systemic gene therapy for glioblastoma
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
The mayo gbm xenograft national resource
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Targeting epha2 in glioblastoma
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Targeting mechanisms of acquired temozolomide resistance in glioblastoma
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Selective targeting of glioma stem cells through sema3c/plexind1
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Ubiquitination and deubiquitination of c-myc in glioblastoma
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Chromatin modifications in gbm-propagating cells
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Cellular plasticity and equilibrium in gbm progression
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Characterization of a microrna network regulating glioblastoma epigenetics; cell reprogramming and dna repair
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Contributions of idh1 mutation to alternative lengthening of telomeres in lower-grade glioma
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Dual targeting of brain tumor initiating cells through inhibition of bmi1 and ezh2
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Exploiting mtap deletion for gbm therapeutics
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Interplay between ubiquitination and epigenetic regulation of egfr signaling in gliomagenesis.
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Mechanism of regulation of progenitor proliferation and transformation
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Mechanisms of riok2 function in glioblastoma
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
The role of tumor associated macrophages in glioblastoma
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Targeting hyaluronan-mediated motility receptor in glioblastoma stem cells
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Targeting kif11 to treat glioblastoma invasion and proliferation
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
The immunosuppressive role of glioblastoma-derived macrophage migration inhibitor factor
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Uncovering therapeutic targets in pediatric high grade gliomas with the h3k27m mutation
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Translational investigation of xpo1 inhibition in high-grade glioma and diffuse intrinsic pontine glioma
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Tissue factor as a key determinant of idh1 mutant versus idh1 wild-type glioma thrombosis and malignancy
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Single cell analysis of the infiltrative margins of glioblastoma and post-treatment recurrence
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Engineering stem cell therapies to understand and overcome glioblastoma adaption
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Physical-chemical aspects of cell and tissue excitability
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Therapeutically relevant targets of twist1 dimers in glioma
Institution: Information not provided - US
Wieloośrodkowy projekt badawczy
- St. Anna Kinderkrebsforschung
- Children's Cancer Research Institute
- Institution: Information not provided - DE
- Institution: Information not provided - IT
- Fondazione IRCCS Istituto Nazionale dei Tumori
- S.S. di Epidemiologia Valutativa
- Fondazione IRCCS Istituto Nazionale dei Tumori
- S.S. di Epidemiologia Valutativa
- University Hospital of Wales
- Department of Haematology
- Northern Institute for Cancer Research, Medical School, Newcastle University
- Northern Institute for Cancer Research
- Institut Curie
- Macromolécules et Microsystèmes en Biologie et en Medecine
- Deutsches Krebsforschungszentrum
- KITZ - Hopp-Kindertumorzentrum Heidelberg
- Universitäts-Kinderklinik Würzburg
- Kinderklinik und Poliklinik
- University College Dublin
- Systems Biology Ireland
- Istituto Ortopedico Rizzoli - Centro di Ricerca e Poliambulatorio
- S.C. Laboratorio di Oncologia Sperimentale
- St. Anna Kinderkrebsforschung
- Children's Cancer Research Institute
- St. Anna Kinderkrebsforschung
- Children's Cancer Research Institute
- Institution: Information not provided - DE
- Institution: Information not provided - ES
- Institution: Information not provided - FR
- Institution: Information not provided - FR
- Fondazione IRCCS Istituto Neurologico "Carlo Besta"
- Fondazione I.R.C.C.S. Istituto Neurologico "C. Besta"

WIEN
WIEN
DIRECT: disseminate research funded by EC improving treatment options for children suffering from cancer

Berlin
ADDRESS: NOT PROVIDED - DE
TORPEDO: Targeting Of Resistance in PEDiatric Oncology

EMILIA ROMAGNA
ADDRESS: NOT PROVIDED - IT
TRANSCAN-2: Aligning national/regional translational cancer research programmes and activities

LOMBARDIA
MILANO
RARECARE: surveillance of rare cancers in Europe

LOMBARDIA
MILANO
RARECARENet: Network informativo sui tumori rari

South Glamorgan
CARDIFF
South East Wales Cancer Network

Tyne & Wear
NEWCASTLE UPON TYNE
EPOC: European paediatric oncology off-patent medicines consortium

ILE-DE-FRANCE
ORSAY
CAMINEMS: Integrated Micro-Nano-Opto Fluidic systems for high-content diagnosis and studies of rare cancer cells

Baden-Württemberg
HEIDELBERG
BRCAddict: Harnessing BRCAness as a therapeutic target in high-risk pediatric solid tumors

Bayern
WÜRZBURG
ATRTPepVac: Exploiting the peptidome of atypical teratoid/rhabdoid tumors - characterization of novel tumor-associated antigens for immunotherapy in order to maintain long-term remissions

County Dublin
DUBLIN 4
ASSET: Analysing and Striking the Sensitivities of Embryonal Tumours

EMILIA ROMAGNA
BOLOGNA
PROTHETS: prognosis and therapeutic targets in the 'Ewing' family of tumors (FINISHED)

WIEN
WIEN
SIOPEN-R-NET: European society of paediatric oncology neuroblastoma research network

WIEN
WIEN
ONTHETRRAC: Overcoming Neuroblastoma Tumour HETerogeneity, Resistance and RecurrAnCe

Berlin
ADDRESS: NOT PROVIDED - DE
LIQUIDHOPE:: Advancing Liquid Biopsies for Monitoring and Personalized Treatment of Children with Neuroblastomas

Madrid
ADDRESS: NOT PROVIDED - ES
PRIMAGE: PRedictive In-silico Multiscale Analytics to support cancer personalized diaGnosis and prognosis, Empowered by imaging biomarkers

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
IMMUNOGLIO: Deciphering immune response against glioblastoma to find new targets

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
GLIOMA-PRD: Multi-parametric analysis of the evolution and progression of low grade glioma

LOMBARDIA
MILANO